About Capstan Therapeutics
Capstan Therapeutics is a company based in San Diego (United States) founded in 2021 by Christian Homsy and Haig Aghajanian was acquired by AbbVie in July 2025.. Capstan Therapeutics has raised $340 million across 3 funding rounds from investors including AbbVie, Lilly and Pfizer. Capstan Therapeutics offers products and services including Science Platform. Capstan Therapeutics operates in a competitive market with competitors including Moderna, BeiGene, Incyte, MorphoSys and Sana Biotechnology, among others.
- Headquarter San Diego, United States
- Founders Christian Homsy, Haig Aghajanian
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Capstan Therapeutics
Capstan Therapeutics offers a comprehensive portfolio of products and services, including Science Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for advancing therapeutics pipelines
Unlock access to complete
Unlock access to complete
Funding Insights of Capstan Therapeutics
Capstan Therapeutics has successfully raised a total of $340M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $175 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $175.0M
-
First Round
First Round
(24 Nov 2021)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series B - Capstan Therapeutics | Valuation | RA Capital Management | |
| Jun, 2022 | Amount | Series A - Capstan Therapeutics | Valuation | Pfizer | |
| Nov, 2021 | Amount | Seed - Capstan Therapeutics | Valuation | Novartis Venture Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Capstan Therapeutics
Capstan Therapeutics has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include AbbVie, Lilly and Pfizer. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on lifescience and healthcare sectors
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Capstan Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Capstan Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Capstan Therapeutics Comparisons
Competitors of Capstan Therapeutics
Capstan Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, MorphoSys and Sana Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Capstan Therapeutics
Frequently Asked Questions about Capstan Therapeutics
When was Capstan Therapeutics founded?
Capstan Therapeutics was founded in 2021.
Where is Capstan Therapeutics located?
Capstan Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Capstan Therapeutics?
Laura Shawver is the current CEO of Capstan Therapeutics.
Is Capstan Therapeutics a funded company?
Capstan Therapeutics is a funded company, having raised a total of $340M across 3 funding rounds to date. The company's 1st funding round was a Seed of $63M, raised on Nov 24, 2021.
What does Capstan Therapeutics do?
Capstan Therapeutics was founded in 2021 and is based in San Diego, United States. Focus is placed on biotechnology, specifically the development of cell therapies targeting oncology, fibrosis, inflammation-related conditions, and monogenic blood disorders. Targeted lipid nanoparticles, CAR-based immunotherapy, and nucleic acid delivery systems are employed to create treatment options. Operations center on advancing these technologies for patient applications in the sector.
Who are the top competitors of Capstan Therapeutics?
Capstan Therapeutics's top competitors include Moderna, BeiGene and Janux Therapeutics.
What products or services does Capstan Therapeutics offer?
Capstan Therapeutics offers Science Platform.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.